II. Indications

  1. Decision Rule to individualize duration of Dual Antiplatelet Therapy (DAPT) after MI or PCI

III. Criteria

  1. Age (Select one of the following)
    1. Score -2: Age 75 years or older
    2. Score -1: Age 65 to 75 years old
    3. Score 0: Age <65 years old
  2. Add 1 point for each of the following criteria
    1. Current Tobacco smoker
    2. Diabetes Mellitus
    3. Myocardial Infarction at presentation
    4. Prior Myocardial Infarction or PCI (Percutaneous Coronary Intervention)
    5. Stent diameter <3 mm
    6. Paclitaxel-eluting stent
  3. Add 2 points for each of the following criteria
    1. Congestive Heart Failure or LV ejection fraction <30%
    2. Saphenous vein graft PCI

IV. Interpretation

  1. Score 2 or greater
    1. Prolonged use of dual antiplatelet drugs is supported (DAPT benefits outweight risks)
  2. Score <2
    1. Shorter duration of dual antiplatelet drugs is preferred (DAPT risks outweigh benefits)

Images: Related links to external sites (from Bing)

Related Studies (from Trip Database) Open in New Window